NasdaqGS:IDXXMedical Equipment
Raised 2025 Guidance and Share Buyback Might Change The Case For Investing In IDEXX Laboratories (IDXX)
IDEXX Laboratories recently updated its full-year 2025 outlook, raising revenue and earnings guidance, and disclosed the completion of another share repurchase tranche totaling 715,526 shares for US$328.53 million, as part of a long-running buyback program.
Strong quarterly results, driven by increasing diagnostics recurring revenue and higher IDEXX inVue Dx instrument placements, highlight continued operational momentum and positive shifts in business performance.
We'll review how stronger...